Thus, it is not surprising that SSc epidermis presents a variety of abnormalities including altered differentiation, active TGF-β signaling, increased production of antimicrobial peptides, with DAMP properties, enhanced capacity to stimulate lattice contraction and inflammatory responses in dermal fibroblasts [112–117]. This evidence concerns the gene TGFB1 and systemic sclerosis.